Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.
about
Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activityInsights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionClinical and laboratory characteristics, staging, and outcomes of individuals with AIDS-associated Kaposi's sarcoma at an university hospital'Et tu, inhibitor?': the potential for HIV inhibitors to prime P-gp-mediated chemoresistance in cancer.
P2860
Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exposure to HIV-protease inhib ...... B1) in Kaposi's sarcoma cells.
@ast
Exposure to HIV-protease inhib ...... B1) in Kaposi's sarcoma cells.
@en
type
label
Exposure to HIV-protease inhib ...... B1) in Kaposi's sarcoma cells.
@ast
Exposure to HIV-protease inhib ...... B1) in Kaposi's sarcoma cells.
@en
prefLabel
Exposure to HIV-protease inhib ...... B1) in Kaposi's sarcoma cells.
@ast
Exposure to HIV-protease inhib ...... B1) in Kaposi's sarcoma cells.
@en
P2093
P2860
P356
P1476
Exposure to HIV-protease inhib ...... CB1) in Kaposi's sarcoma cells
@en
P2093
G M De Donatis
J-P Gillet
M M Gottesman
P2860
P2888
P304
P356
10.1038/BJC.2011.275
P407
P577
2011-08-01T00:00:00Z